Cargando…
A purinergic P2Y6 receptor agonist prodrug modulates airway inflammation, remodeling, and hyperreactivity in a mouse model of asthma
BACKGROUND: Purinergic receptors control cell proliferation, apoptosis, migration, inflammation, and cytokine secretion. Increased expression of specific purinergic receptors is reported in asthma. The role of purinergic P2Y6 receptors (P2Y6R) in asthma is controversial. HYPOTHESIS: P2Y6R activation...
Autores principales: | Chetty, Anne, Sharda, Azeem, Warburton, Rod, Weinberg, Ellen O, Dong, Jinghui, Fang, Min, Sahagian, G Gary, Chen, Tiangmeng, Xue, Chang, Castellot, John J, Haydon, Philip G, Nielsen, Heber C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078081/ https://www.ncbi.nlm.nih.gov/pubmed/30122959 http://dx.doi.org/10.2147/JAA.S151849 |
Ejemplares similares
-
Glucagon reduces airway hyperreactivity, inflammation, and remodeling induced by ovalbumin
por: Insuela, Daniella B. R., et al.
Publicado: (2019) -
Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity
por: Galle-Treger, Lauriane, et al.
Publicado: (2016) -
Resveratrol has protective effects against airway remodeling and airway hyperreactivity in a murine model of allergic airways disease
por: Royce, Simon G., et al.
Publicado: (2011) -
Unexpected sirolimus-stimulated airway hyperreactivity in lymphangioleiomyomatosis
por: Steagall, Wendy K., et al.
Publicado: (2023) -
PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity
por: Helou, Doumet Georges, et al.
Publicado: (2020)